A better understanding of the mechanisms involved in megakaryocyte maturation will facilitate the generation of platelets in vitro and their clinical applications. A microRNA, miR-125b, has been suggested to have important roles in the self-renewal of megakaryocyte-erythroid progenitors and in platelet generation. However, miR-125b is also critical for hematopoietic stem cell selfrenewal. Thus, the function of miR-125b and the complex signaling pathways regulating megakaryopoiesis remain to be elucidated. In this study, an attentive examination of the endogenous expression of miR-125b during megakaryocyte differentiation was performed. Accordingly, the differentiation of hematopoietic stem cells requires the downregulation of miR-125b, whereas megakaryocyte determination and maturation synchronize with miR-125b accumulation. The overexpression of miR-125b improves megakaryocytic differentiation of K562 and UT-7 cells. Furthermore, stage-specific overexpression of miR-125b in primary cells demonstrates that miR-125b mediates an enhancement of megakaryocytic differentiation after megakaryocyte determination, the stage at which megakaryocytes are negative for the expression of the hematopoietic progenitor marker CD34. The identification of miR-125b targets during megakaryopoiesis was focused on negative regulators of cell cycle because the transition of the G1/S phase has been associated with megakaryocyte polyploidization. Real-time PCR, western blot and luciferase reporter assay reveal that p19
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INK4D is a direct target of miR-125b. P19 INK4D knockdown using small interfering RNA (siRNA) in megakaryocyte-induced K562 cells, UT-7 cells and CD61
+ promegakaryocytes results in S-phase progression and increased polyploidy, as well as improved megakaryocyte differentiation, similarly to the effects of miR-125b overexpression. P19 INK4D overexpression reverses these effects, as indicated by reduced expression of megakaryocyte markers, G1-phase arrest and polyploidy decrease. P19
INK4D knockdown in miR-125b downregulated cells or p19 INK4D overexpression in miR-125b upregulated cells rescued the effect of miR-125b. Taken together, these findings suggest that miR-125b expression positively regulates megakaryocyte development since the initial phases of megakaryocyte determination, and p19
INK4D is one of the key mediators of miR-125b activity during the onset of megakaryocyte polyploidization. Cell Death and Disease (2016) 7, e2430; doi:10.1038/cddis.2016.288; published online 20 October 2016 Thrombocytopenia, the deficiency of platelets (PLTs) in the blood, threatens millions of people, including patients undergoing high-dose chemotherapy, and subjects affected by aplastic anemia or hepatitis virus-related cirrhosis. The cells responsible of PLT production are the megakaryocytes (MK). Polyploidization is an important step during MK maturation and PLT generation. To understand the mechanisms underlying MK maturation will facilitate ex vivo PLT manufacture for therapeutic applications and clinical treatments of thrombocytopenia.
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression primarily by inhibiting the translation of target mRNAs through direct binding of specific sites in the 3′-untranslated region (3′-UTR). 1 It is now commonly accepted that miRNAs has essential roles in hematopoiesis, including embryonic stem cell differentiation, erythropoiesis, granulocytopoiesis/monocytopoiesis, lymphopoiesis and megakaryocytopoiesis. 2 During MK determination and maturation, miR-155 blocks megakaryocytic differentiation by targeting Ets-1 and Meis1 transcription factors, miR-150 drives MK-erythroid precursors toward the megakaryocytic fate via the inhibition of the target transcription factor c-Myb and miR-34a enhances MK differentiation in hematopoietic stem cells (HSCs) through the repression of c-Myb and MEK1 expression.
found to have a direct correlation with the pathogenesis of acute megakaryoblastic leukemia in Down syndrome patients. Therefore, it is crucial to uncover the correlation between miR-125b and megakaryocytopoiesis. Although the study by Klusmann et al. 4 suggests that Dicer and ST18 were direct targets of miR-125b in megakaryocytopoiesis, both of these factors are common to several cellular processes. 6 Considering the significant effect of miR-125b on cell proliferation and endomitosis of MK progenitors and MKs, it is reasonable to speculate that miR-125b may regulate the expression of cellcycle inhibitors. In this study, we systematically identified the role of miR-125b in the differentiation of MKs and one of the target genes that mediate its function, the cell-cycle inhibitor p19 INK4D .
Results
Endogenous expression of miR-125b increases during MK differentiation and PLT production. To gain insight into the role of miR-125b in MK differentiation, we investigated the endogenous expression of miR-125b in HSC-MK differentiation. First, we examined the total cellular expression of miR-125b in differentiating megakaryoid cells. RNA was collected every 3 days, starting from day 0 over 15 days of induction. To evaluate megakaryocytic maturation and enrichment, we analyzed the expression of the megakaryocytic surface markers CD41 (GPIIb) and CD61 (GPIIIa/β3). The elevated expression of these MK biomarkers (CD41 and CD61) in the cultures is shown in Figure 1a . miR-125b expression decreased during the first 6 days of in vitro differentiation, and then slightly increased after day 6 of culture. The expression of miR-125b was markedly elevated in PLTs isolated from cord blood (CB) (Figure 1b ) (4200-fold) compared with undifferentiated CD34 + hematopoietic cells (Figure 1d , left panel). Although miR-125b expression in primary cells exhibited a certain degree of variability among the individual donors, it progressively and markedly increased in PLTs in all of the samples analyzed.
We then attempted to separate mature and immature MKs based on the different fluorescence intensity of the MK markers. CB cells cultured for 15 days were chosen for FACS sorting. Three populations were separated according to the expression levels of CD41 and CD61 (Figure 1c) (Figures 2a-c) . This phenotype suggests that PMA treatment facilitates the production of MKs. When comparing miRNA expression in untreated cells and in cells cultured for 3 days with PMA, an upregulation of miR-125b by 6.5-fold was observed after PMA treatment in K562 cells (Figure 2d, top panel) . Similarly, megakaryocytic differentiation of UT-7 cells resulted in the enrichment (10-fold) of miR-125b ( Figure 2d , bottom panel). Thus, MK differentiation of HSCs, K562 cells and UT-7 cells was associated with an increased expression of miR-125b. These observations suggest that miR-125b might be positively associated with megakaryocytic differentiation.
Effect of miR-125b overexpression or downregulation on MK differentiation. Endogenous expression of miR-125b is low in two human leukemia cell lines, K562 and UT-7. Therefore, we overexpressed miR-125b in K562 and UT-7 cells to determine whether the upregulation of miR-125b observed during MK differentiation has a role in controlling MK maturation. Successful overexpression of mature miR-125b in both cell lines is shown in Figure 3a . Subsequently, the cells were cultured in medium containing 1 nM PMA to induce megakaryotic differentiation and maturation. Overexpression of miR-125b promoted the expression of MK integrins ( Figure 3c ). Another indicator of MK differentiation is the expression of genes important for MK lineage, which regulate lineage-specific differentiation of MKs and characterize the maturation of human MKs (megakaryocytic genes). Similarly to what was observed by flow cytometry, higher expression of CD61 and other important megakaryocytic genes was also detected by quantitative RT-PCR (qPCR) in pcDNA3.1-pri-miR-125b cells when compared with control cells, which is consistent with previous observations (Figure 3b ).
Cessation of cell proliferation is a hallmark of terminal differentiation. 9 Hence, we examined whether cell proliferation was altered by miR-125b overexpression. At 72 h after PMA treatment, the cell amplification blockage resulting from miR-125b overexpression was more remarkable in K562 cells (Figure 3d ). And after additional 6 days of treatment, the increase in cell size and ploidy level was evident ( Figure 3e We further determined whether miR-125b also contributes to MK differentiation of primary human hematopoietic stem and progenitor cells. For this purpose, miR-125b expression was modified in human CB mononuclear cells (MNCs). The cells were grown in megakaryocytic differentiation medium and transfected on day 1 with miR-125b mimics or non-target negative control (NC) mimics. Transfection of miR-125b mimics increased miR-125b levels of is~30-fold compared with NC cells (Figure 4a ). Then, we evaluated the effect of miR-125b overexpression on MK markers and megakaryocytic genes. Subsequently, MNCs were transfected with miR-125b inhibitor mimics or non-target NC inhibitors. By using specific inhibitors, miR-125b expression was successfully downregulated over fivefold in MNCs (Figure 4d Role of miR-125b in megakaryocyte maturation M Qu et al and 14.5%, whereas in the NC inhibitor control cells, the corresponding percentages were 41% and 15.6%, respectively (Figure 4e ). qPCR analysis revealed that treatment with miR-125b inhibitors repressed megakaryocytic genes when compared with the NC inhibitor group (Figure 4f ). In summary, the overexpression of miR-125b increases MK differentiation of MNCs, whereas the suppression of miR-125b inhibited MK differentiation. However, the effect of miR-125b overexpression in MNCs was not as robust as in K562 or UT-7 cells.
Alteration of miR-125b in human HSCs, CFU-MK cells and pro-MKs exerts different effects on MK differentiation. The positive effect of miR-125b on megakaryopoiesis has been elucidated previously. 4 However, modification of During megakaryopoiesis, the expression of CD61 showed the most marked and progressive increase over time, while surface expression of CD34 decreased. 10 Using wellestablished surface markers, we purified three populations of cells. We refer to them as: HSCs CD34 . Magnetic cell sorting (MACS) technology was used to isolate the three populations from human CB MNCs before or after MK differentiation in vitro. After separation, we stained the cells with antibodies against CD34 and CD61, and examined the endogenous expression of miR-125b (Figures 5a-c) . Subsequently, miR-125b expression was modified in HSCs, CFU-MKs and pro-MKs (Figures 5d, g, j, m, p and s), followed by 5 days MKspecific induction and detection.
For HSCs and CFU-MKs, gain or loss of function of miR-125b did not result in a significant alteration of the percentage of CD61 + and CD41 + populations and cellular morphology after the induction of differentiation (Figures 5d-o and Supplementary Figures S1A and B) .
Studies with promegakryocytes demonstrated that both early (CD41 and CD61) and late (CD42b) megakaryocytic surface markers could be detected by flow cytometry after induction. And the overexpression of miR-125b promoted the expression of all these MK differentiation markers (Figure 5q and Supplementary Figure S1C) . When comparing MK maturity by cellular morphology, pro-MKs with miR-125b mimics show more mature MK phenotypes, the huger and higher polyploid (8N or more), than NC mimics (Figure 5r) . Moreover, miR-125b inhibitor significantly retarded MK differentiation as assessed by comparing cellular morphology and expression of the megakaryocytic surface markers (Figures 5t-u) . Concomitantly, we evaluated the number of PLT released in culture media. From the same number of seeded pro-MKs, we obtained more PLTs in miR-125b-transfected pro-MKs than the NC cells and less in miR-125b decreased expression than with NC inhibitor ( Supplementary  Figures S1F-G) .
To confirm the function of miR-125b at distinct stages of MK development, a CFU-MK colony formation assay was also performed to quantitate the megakaryocytic potential of the progenitor cells. As we known, neonatal MK progenitors are hyperproliferative and generate more MKs per colony, although the colony cells are smaller and less polyploid compared with adult progenitors that generate more PLTs per MK. 11 As a consequence, large MK colonies arise from more primitive MK progenitors, whereas smaller MK colonies are produced by more mature MK progenitors. Therefore, we subdivided the colonies based on their size: small (3-20 cells per colony), medium (21-49 cells per colony) and large (⩾50 cells per colony). We found that in HSCs, forced miR-125b expression resulted in more CFU-GEMM and large CFU-MK units, but had no effect on medium and small CFU-MK units (Figures 5v-x) , suggesting a uniform effect of miR-125b on all the myeloid lineages at this stage. Sorted CFU-MKs and Role of miR-125b in megakaryocyte maturation M Qu et al pro-MKs could not derive myeloid colonies except for megakaryocytic colonies (data not shown). For these cells, miR-125b overexpression resulted in a statistically significant increase in total MK colony-forming units, especially in small CFU-MK units, but showed no effect on large CFU-MK units. In contrast, loss of miR-125b function showed a marked decrease in megakaryocytic colony formation (Figures  5w-z) . In conclusion, these gain-and loss-of-function experiments strongly suggest that miR-125b promotes MK differentiation at a late stage of maturation.
The G1 cell-cycle inhibitor p19 INK4D is a target of miR-125b during megakaryopoiesis. In silico prediction of miRNA targets suggests that thousands of mRNAs could be regulated by miR-125b at the transcriptional or posttranscriptional level. Few studies have noted that miR-125b has different functions in different cellular contexts. 12 In megakaryocytopoiesis, a previous report 5 and our study both demonstrated the important role that miR-125b has in MK endomitosis, which results in the polyploidy of MKs. Accordingly, we narrowed our analysis of potential miR-125b targets in megakaryopoiesis to cell-cycle regulators, especially to the INK4 family, whose members have been suggested to have a pivotal role in G1 cell-cycle suppression and MK endomitosis. 13 By consulting relevant literatures and performing integrative bioinformatic analysis, we identified potential miR-125b binding sites in the 3′-UTRs of p16 
